Återgå till huvudnavigering
Återgå till sök
Gå direkt till huvudinnehållet
Lunds universitet Hem
English
Svenska
Hem
Profiler
Forskningsoutput
Projekt
Enheter
Infrastruktur
Aktiviteter
Priser och utmärkelser
Sök efter expertis, namn eller tillhörighet
Olof Gidlöf
Forskare, biträdande, Docent
Docent, Principal Investigator, Forskare
,
Kardiologi
Forskningsprojektdeltagare
,
Molecular Epidemiology and Cardiology
Forskningsprojektdeltagare
,
Molekylär kardiologi
Projektledare
,
Cardiovascular Epigenetics
Forskare
,
EXODIAB: Excellence of Diabetes Research in Sweden
Telefon
+46462224707
E-postadress
olof.gidlof
med.lu
se
Översikt
Fingeravtryck
Nätverk
Forskningsoutput
(48)
Projekt
(4)
Liknande profiler
(6)
Handlett arbete
(4)
Fingeravtryck
Utforska forskningsämnen där Olof Gidlöf är aktiv. Dessa ämnesetiketter kommer från personens arbeten. Tillsammans bildar de ett unikt fingeravtryck.
Sortera efter
Vikt
Alfabetisk ordning
Biochemistry, Genetics and Molecular Biology
Acoustics
40%
Antisense
13%
Apoptosis
32%
Atrial Natriuretic Peptide
27%
Cardiac Arrest
13%
Cardiac Muscle Cell
21%
Cell Membrane
13%
Centrifugation
27%
Cyclic Adenosine Monophosphate
14%
Downregulation
16%
Downstream Processing
6%
Eicosanoid Receptor
43%
Enhancer Region
6%
Flow Cytometry
18%
Gene
27%
Gene Expression Profiling
18%
Genetic Divergence
16%
Genetics
10%
Heart Ejection Fraction
15%
Light
7%
Long Non-Coding RNA
13%
Mechanistic Target of Rapamycin
13%
Messenger RNA
13%
Metabolite
13%
Metabolome
13%
MicroRNA
97%
Microvesicles
6%
Missense
13%
Natriuretic Peptide
13%
Osteoblast
13%
P2Y12
13%
Peptide
7%
Phosphoinositide 3-Kinase
13%
Polygenic Score
13%
Protein
75%
Proteome
21%
Proteomics
44%
Randomized Clinical Trial
13%
Rat Model
13%
Real-Time Polymerase Chain Reaction
23%
Regulatory Mechanism
16%
Reperfusion
18%
RNA
12%
Screening
10%
Single Nucleotide Polymorphism
13%
Staining
7%
Survival
7%
Volume
33%
Whole Genome Sequencing
13%
YWHAE
13%
Medicine and Dentistry
Adult
13%
Antiapoptotic
13%
Association
13%
Biogenesis
13%
Biological Marker
7%
Blood
21%
Brain
14%
Cardiovascular System
13%
Cathelicidin Antimicrobial Peptide LL 37
27%
Cells
15%
Coronary Flow Reserve
13%
Death
7%
Disease
8%
Endothelial Cell
31%
Extracellular Trap
7%
Follow up
6%
Heart Arrest
13%
Heart Graft
13%
Heart Transplantation
29%
Hypothermia
15%
In Vitro
5%
Induced Hypothermia
5%
Liver
15%
microRNA
100%
Mortality
31%
Multiple Reaction Monitoring
13%
Myocardial Infarction
18%
Osteoblast
13%
Out of Hospital Cardiac Arrest
13%
Patient
71%
Platelet
9%
Programmed Cell Death
15%
Real-Time Polymerase Chain Reaction
8%
Serum
13%
Therapeutic Procedure
7%
Therapeutics
32%
Thymic Stromal Lymphopoietin
13%
Transcriptomics
13%
Transplantation
15%
Vascular Remodeling
13%
Vasculitis
13%
Pharmacology, Toxicology and Pharmaceutical Science
Apoptosis
15%
Cardiovascular Disease
11%
Cell Viability
9%
Clopidogrel
8%
Disease Marker
9%
Elimination
13%
Flow Cytometry
8%
Heart Infarction
61%
Inflammation
5%
Membrane Metalloendopeptidase
9%
microRNA 1
6%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
5%
P-Selectin
14%
Pharmacodynamics
13%
Phosphatidylinositol 3 Kinase
13%
Prasugrel
14%
Prognosis
17%
Purinergic P2Y12 Receptor
13%
Rat Model
13%
Receptor
9%
ST Segment Elevation Myocardial Infarction
36%
Succinic Acid
13%
Thorax Pain
13%
Triton X-100
5%
